Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Pre-Tax Income : ¥311 Mil (TTM As of Mar. 2024)

Hangzhou Bio-Sincerity Pharma-Tech Co Pre-Tax Income Chart

Hangzhou Bio-Sincerity Pharma-Tech Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															32.36	95.35	96.65	71.32	47.90

Competitive Comparison of Hangzhou Bio-Sincerity Pharma-Tech Co's Pre-Tax Income

For the Drug Manufacturers - General subindustry, Hangzhou Bio-Sincerity Pharma-Tech Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Bio-Sincerity Pharma-Tech Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hangzhou Bio-Sincerity Pharma-Tech Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Hangzhou Bio-Sincerity Pharma-Tech Co's Pre-Tax Income falls into.

Hangzhou Bio-Sincerity Pharma-Tech Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Hangzhou Bio-Sincerity Pharma-Tech Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Hangzhou Bio-Sincerity Pharma-Tech Co's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥311 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Bio-Sincerity Pharma-Tech Co  (SZSE:301096) Pre-Tax Income Explanation

Hangzhou Bio-Sincerity Pharma-Tech Co's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

During the past 7 years, Hangzhou Bio-Sincerity Pharma-Tech Co's highest Pretax Margin was 32.62%. The lowest was -35.95%. And the median was 31.43%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Bio-Sincerity Pharma-Tech Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Hangzhou Bio-Sincerity Pharma-Tech Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Business Description